EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
January 16 2024 - 6:15PM
As previously disclosed, EUDA Health Holdings Limited (“EUDA” and
the “Company”) received a written notice from Nasdaq on January 9,
2024 indicating that the Company had failed to maintain a minimum
market value of listed securities of $35 million over the previous
30 consecutive business days (the “MVLS Requirement”) as required
by the Nasdaq Listing Rule 5550(b)(2).
On January 16, 2024, the Company received a
written notice from Nasdaq stating that the Company’s Market Value
of Listed Securities has been $35 million or greater for ten
consecutive business days from January 2 to January 16, 2024, and
therefore the Company has regained compliance with the MVLS
requirement for continued listing on the Nasdaq Capital Market.
For investor and media inquiries, please
contact:Dr. Kelvin ChenChief Executive
OfficerEUDA Health Holdings Limitedkelvin@euda.com
Euda Health (NASDAQ:EUDA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Euda Health (NASDAQ:EUDA)
Historical Stock Chart
From Dec 2023 to Dec 2024